Pfizer tests Covid pill as preventive medicine
The Peninsula
NEW YORK - Pfizer has started testing its potential COVID-19 treatment as a preventive medicine aimed at warding off the virus if a close contact gets it.
The drugmaker said Monday that it will study the pill it is developing in combination with a low dose of the HIV drug ritonavir in people who are at least 18 years old and live in the same household with someone who is infected.
Pfizer plans to enroll 2,660 people in the late-stage study. Those participating will get either the treatment combination or a fake drug orally twice a day for five to 10 days.
More Related News
Sidra Medicine launches masterclasses ahead of Precision Medicine and Future of Genomics 2024 Summit
Doha, Qatar: In anticipation of the upcoming Precision Medicine and the Future of Genomics 2024 Summit (PMFG 2024), Sidra Medicine, a Qatar Foundation...